Angela F. Braly had substantial holdings in Elevance Health during her time as CEO, with her wealth largely tied to the company’s performance. At her peak in 2010, her total compensation reflected over $13 million, bolstered by a mixture of...

Angela F. Braly had substantial holdings in Elevance Health during her time as CEO, with her wealth largely tied to the company’s performance. At her peak in 2010, her total compensation reflected over $13 million, bolstered by a mixture of salary, bonuses, and stock awards. Her stock options and restricted units were significant, indicating a substantial investment in the company’s future. Notably, her holdings but changed when her tenure ending in 2012 caused many stock awards to cancel, showcasing the volatility in executive wealth as company performance dips. At the height of her career at Elevance, she owned over 1.1 million shares directly and held substantial unvested options, which illustrated her committed stake in the company's success. However, once she parted ways with Elevance, her financial ties shifted quickly as unvested awards faced termination, pointing out the risks involved in executive compensation tied to company performance.